Myelotoxicuty of high-molecular-weight poly(ethylene oxide)

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 67, Issue 6, 2004, Pages 61-65

  Karpova, G V ^a   Abramova, E V ^a   Lamzina, T Yu ^a   Timina, E A ^a   Vetoshkina, T V ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(ETHYLENE OXIDE); POLYMER; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TOXICITY; CONTROLLED STUDY; CYTOLYSIS; DOSE RESPONSE; FREEZE DRYING; HEMOLYTIC ANEMIA; LETHAL DOSE; LEUKOCYTOSIS; LYMPHOCYTOPENIA; MAXIMUM TOLERATED DOSE; MOLECULAR WEIGHT; NONHUMAN; RAT; SOLUBILITY; THROMBOCYTOPENIA; ANIMAL; BONE MARROW; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEMATOLOGIC DISEASE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE;

ANEMIA, HEMOLYTIC; ANIMALS; BONE MARROW; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOLOGIC DISEASES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MALE; POLYETHYLENE GLYCOLS; RATS;

EID: 12144273459     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. P. I. Polimeni and B. T. Otttenbreit, J. Cardiovasc. Pharmacol., 14(3), 374 - 380 (1989).
2. P. D. Stein, E. D. Parsons, and E. F. Blick, Med. Res. Eng., 11(5), 6 - 10 (1972).